India · Delayed Price · Currency is INR Jupiter Life Line Hospitals Earnings Call Transcripts
Fiscal Year 2026
-
FY 2026 saw strong 15%+ growth in revenue and EBITDA, with robust expansion plans adding 1,700 beds across Mumbai and Pune. Dombivli hospital opened ahead of schedule, and the group remains cash positive, funding growth through internal accruals and capped debt.
-
Dombivli hospital launched ahead of schedule, but will initially weigh on margins as it ramps up. Q3 saw 9.8% revenue growth and stable EBITDA margins, though PAT declined due to a one-time labor code provision. Mature hospitals are stable, while Indore and new projects drive future growth.
-
Q2 and H1 FY26 saw double-digit revenue and EBITDA growth, with margins stable despite new bed additions. Dombivli Hospital is on track for Q1 launch next year, with new accounting for unbilled revenue and a one-off provision impacting results. Debt remains low-cost and well-covered by liquidity.
-
Q1 FY26 saw 20.5% revenue growth and 19.6% EBITDA growth, but PAT declined 1.6% due to higher depreciation and finance costs. Occupancy and patient volumes rose, with strong ARPOB growth from price hikes and case mix. Renewable energy investments and greenfield expansions continue.
Fiscal Year 2025
-
Q4 income rose 12.1% year-on-year to INR 326.7 crores, with EBITDA margin at 23.9% and PAT margin at 13.7%. Expansion continues with new beds, greenfield projects, and prudent debt, while ARPOB growth is expected to align with inflation.
-
Revenue and profitability grew strongly year-over-year, with Q3 FY25 income up 17.7% and PAT up 20.1%. Expansion plans include three new hospitals, all funded through internal accruals, with no immediate need for debt. Occupancy and RPOB also improved.
-
Q2 and H1 FY25 saw strong revenue and profit growth, with expanding margins and occupancy rates. Major CapEx is focused on new greenfield hospitals in Dombivli and Pune, while Indore and Pune continue to add capacity. Regulatory delays and expansion may temporarily impact occupancy metrics.
-
Q1 FY 2025 delivered robust growth with 18.2% higher revenue and improved occupancy rates. Expansion in Pune and Indore is on track, with strong cash reserves supporting future growth. Margins are expected to reach 25% as new hospitals mature.